Chemed Corp. Stock
Price
Target price
€510.00
€510.00
-
-
-
€600.54
24.05.24 / Stuttgart Stock Exchange
WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Chemed Corp. Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Chemed Corp..
With a target price of 600 € there is a slightly positive potential of 17.65% for Chemed Corp. compared to the current price of 510.0 €.
So far the community has only identified positive things for Chemed Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Chemed Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chemed Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemed Corp. | - | -0.971% | -3.774% | - | - | - | - |
| Amn Healthcare Svs | -0.970% | -4.673% | -2.857% | -42.697% | -23.881% | -29.167% | 15.975% |
| Ensign Group Inc. | -0.900% | 0.000% | 0.000% | - | 6.796% | - | - |
| Amedisys Inc. | -0.570% | 1.744% | 4.790% | 25.000% | 3.550% | -59.112% | -8.750% |
Comments
Chemed Co. (NYSE: CHE) had its price target lowered by analysts at Royal Bank of Canada from $712.00 to $697.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $604.00 to $712.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
News
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting.
Stockholders ratified the continuation of
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the
Chemed Reports First-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest